Previous Page  2 / 8 Next Page
Information
Show Menu
Previous Page 2 / 8 Next Page
Page Background

Page 13

Notes:

allied

academies

Journal of Microbiology: Current Research | Volume 2

November 01-02, 2018 | London, UK

7

th

European

Clinical Microbiology Congress

4

th

International Conference on

Ophthalmology and Eye Disorder

Joint Event

&

Insights into genetic basis of virulence in

Salmonella

Dublin

Manal Mohammed

University of Westminster, UK

S

almonellosis is one of the most common foodborne

diseases worldwide that causes a huge burden of morbidity

and mortality in humans. Although non-typhoidal

Salmonella

servoars including

Salmonella

Dublin are associated primarily

with self-limiting gastrointestinal illness they have adapted

to cause invasive disease and systemic illness in humans

particularly children, elderly and immunocompromised

people.

Salmonella enterica

serovar Dublin is a zoonotic

infection that can be transmitted from cattle to humans

through consumption of contaminated milk and milk products.

Outbreaks of human infections by

Salmonella

Dublin have been

reported in several countries including high-income countries.

The genetic basis of virulence and invasiveness of

Salmonella

Dublin is not well characterized. We apply next generation

sequencing and associated bioinformatics analyses tools is

characterize the invasome of

Salmonella

Dublin that enable

the bacteria to cause systemic illness in humans. We identified

several virulence factors that enable the bacteria to cause

invasive disease in humans however, no genomic markers were

detected that differentiate among invasive and non-invasive

isolates suggesting that host factors and immune response play

a significant role in the disease outcome. There is no vaccine

against non-typhoidal

Salmonella

however our understanding

of themolecular basis of virulence in invasive

Salmonella

Dublin

will provide insights into thedevelopment of aneffectivevaccine

through identificationof novel virulence-attenuated strainswith

a potential for use as vaccine candidates for high-risk groups.

Speaker Biography

Manal Mohammed is a lecturer in Medical Microbiology at University of Westminster,

UK. She did her PhD at University of Liverpool, UK where she studied the molecular

evolution of incurable Japanese encephalitis virus associated with high morbidity

and mortality in humans. Her research is focused on application of next generation

sequencing technologies and associated bioinformatics analyses tools in investigating

the molecular basis of virulence of non-typhoidal salmonellosis in humans and

understanding the complex dynamics of bacteria-phage interaction aiming to develop

phage therapy as an alternative to antibiotics.

e:

m.mohammed@westminster.ac.uk

Manal Mohammed, Clinical Microbiology and Eye 2018, Volume 2

DOI: 10.4066/2591-8036-C1-002